NCT05917275View on ClinicalTrials.gov

Multi-Omics to Predict the Blood Pressure Response to Antihypertensives

PHASE4RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

April 4, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Primary Hypertension
Interventions
DRUG

Amlodipine

4 weeks of Amlodipine

DRUG

Olmesartan

4 weeks of Olmesartan

DRUG

Hydrochlorothiazide

4 weeks of Hydrochlorothiazide

DRUG

Amlodipine/Olmesartan

4 weeks of Amlodipine/Olmesartan

Trial Locations (1)

Unknown

RECRUITING

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER